Literature DB >> 15251083

Common clinical features and disease mechanisms of psoriasis and psoriatic arthritis.

Wendy Myers1, Mobolaji Opeola, Alice B Gottlieb.   

Abstract

Psoriasis and psoriatic arthritis are chronic inflammatory diseases that significantly affect patients' quality of life. Not only do these diseases impact patients' physical well-being, but also detrimentally affect their life socially and psychologically. There are many different patterns of skin and joint involvement. Understanding the pathogenesis of these diseases has evolved greatly in the past few decades. It is now understood that psoriasis and psoriatic arthritis are T cell mediated disorders. A number of proinflammatory cytokines have been suggested as playing a role in the disease mechanism, such as tumor necrosis factor-alpha and interferon-gamma. Other important factors proposed in the pathogenesis of these diseases include the role of genetics and environmental factors. New immunomodulating therapies, which are being developed as our understanding of the involvement of innate and adaptive immunity advances, will provide patients with safer, more effective, long-term, management options.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15251083     DOI: 10.1007/s11926-004-0043-y

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  30 in total

1.  Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial.

Authors:  U Chaudhari; P Romano; L D Mulcahy; L T Dooley; D G Baker; A B Gottlieb
Journal:  Lancet       Date:  2001-06-09       Impact factor: 79.321

2.  Infectious complications of erythrodermic psoriasis.

Authors:  M S Green; J H Prystowsky; S R Cohen; J I Cohen; M G Lebwohl
Journal:  J Am Acad Dermatol       Date:  1996-05       Impact factor: 11.527

Review 3.  Diagnosis and management of psoriatic arthritis.

Authors:  John Brockbank; Dafna Gladman
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 4.  Pathogenesis of psoriatic arthritis.

Authors:  U Fearon; D J Veale
Journal:  Clin Exp Dermatol       Date:  2001-06       Impact factor: 3.470

Review 5.  Psoriasis.

Authors:  G S Drew
Journal:  Prim Care       Date:  2000-06       Impact factor: 2.907

Review 6.  Psoriasis. Immunopathology and immunomodulation.

Authors:  A B Gottlieb
Journal:  Dermatol Clin       Date:  2001-10       Impact factor: 3.478

7.  The National Psoriasis Foundation Psoriasis Score (NPF-PS) system versus the Psoriasis Area Severity Index (PASI) and Physician's Global Assessment (PGA): a comparison.

Authors:  Alice B Gottlieb; Umesh Chaudhari; Daniel G Baker; Michelle Perate; Lisa T Dooley
Journal:  J Drugs Dermatol       Date:  2003-06       Impact factor: 2.114

Review 8.  Advances in the management of psoriasis: monoclonal antibody therapies.

Authors:  Don Mehrabi; Joshua B DiCarlo; Seaver L Soon; Calvin O McCall
Journal:  Int J Dermatol       Date:  2002-12       Impact factor: 2.736

9.  Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis.

Authors:  Christopher T Ritchlin; Sally A Haas-Smith; Ping Li; David G Hicks; Edward M Schwarz
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

Review 10.  Newly available treatments for psoriatic arthritis and their impact on skin psoriasis.

Authors:  Hassan Galadari; Brian Fuchs; Mark Lebwohl
Journal:  Int J Dermatol       Date:  2003-03       Impact factor: 2.736

View more
  2 in total

1.  Arterial distensibility in chronic inflammatory rheumatic disorders.

Authors:  Mustafa Yildiz
Journal:  Open Cardiovasc Med J       Date:  2010-02-23

2.  Decrease in RNase HII and Accumulation of lncRNAs/DNA Hybrids: A Causal Implication in Psoriasis?

Authors:  Ecmel Mehmetbeyoglu; Leila Kianmehr; Murat Borlu; Zeynep Yilmaz; Seyma Basar Kılıc; Hassan Rajabi-Maham; Serpil Taheri; Minoo Rassoulzadegan
Journal:  Biomolecules       Date:  2022-02-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.